1. Home
  2. LGHL vs TOVX Comparison

LGHL vs TOVX Comparison

Compare LGHL & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGHL
  • TOVX
  • Stock Information
  • Founded
  • LGHL 2015
  • TOVX 2001
  • Country
  • LGHL Singapore
  • TOVX United States
  • Employees
  • LGHL N/A
  • TOVX N/A
  • Industry
  • LGHL Investment Bankers/Brokers/Service
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGHL Finance
  • TOVX Health Care
  • Exchange
  • LGHL Nasdaq
  • TOVX Nasdaq
  • Market Cap
  • LGHL 4.3M
  • TOVX 4.7M
  • IPO Year
  • LGHL N/A
  • TOVX 2006
  • Fundamental
  • Price
  • LGHL $3.50
  • TOVX $1.18
  • Analyst Decision
  • LGHL
  • TOVX Strong Buy
  • Analyst Count
  • LGHL 0
  • TOVX 1
  • Target Price
  • LGHL N/A
  • TOVX $6.00
  • AVG Volume (30 Days)
  • LGHL 61.8K
  • TOVX 23.1K
  • Earning Date
  • LGHL 04-29-2025
  • TOVX 05-06-2025
  • Dividend Yield
  • LGHL N/A
  • TOVX N/A
  • EPS Growth
  • LGHL N/A
  • TOVX N/A
  • EPS
  • LGHL N/A
  • TOVX N/A
  • Revenue
  • LGHL $13,659,110.00
  • TOVX N/A
  • Revenue This Year
  • LGHL N/A
  • TOVX N/A
  • Revenue Next Year
  • LGHL N/A
  • TOVX N/A
  • P/E Ratio
  • LGHL N/A
  • TOVX N/A
  • Revenue Growth
  • LGHL 11.24
  • TOVX N/A
  • 52 Week Low
  • LGHL $2.82
  • TOVX $1.03
  • 52 Week High
  • LGHL $43.00
  • TOVX $12.25
  • Technical
  • Relative Strength Index (RSI)
  • LGHL 32.32
  • TOVX 44.05
  • Support Level
  • LGHL $2.82
  • TOVX $1.08
  • Resistance Level
  • LGHL $4.89
  • TOVX $1.25
  • Average True Range (ATR)
  • LGHL 0.63
  • TOVX 0.08
  • MACD
  • LGHL -0.07
  • TOVX 0.00
  • Stochastic Oscillator
  • LGHL 25.37
  • TOVX 57.89

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: